Mikiko Kudo | Neuroscience Discoveries | Young Scientist Award

Dr. Mikiko Kudo | Neuroscience Discoveries | Young Scientist Award

Kyusyu University | Japan

Mikiko Kudo, PhD, is an Assistant Professor in Molecular Neuroimmunology at the Medical Institute of Bioregulation, Kyushu University. Her research focuses on brain development, neuroimmune interactions, and how maternal and early-life immune environments influence psychiatric and neurodevelopmental disorders. She investigates microglial aging, stress-induced brain macrophage responses, and innate immune regulation during embryonic neurogenesis. Dr. Kudo identified and characterized the novel soluble molecule Akhirin, revealing its role in maintaining neural stem cell niche homeostasis and barrier integrity. She has published in leading neuroscience journals, received competitive research grants, and actively presents her work at international and national scientific conferences.
View Orcid Profile

Featured Publications

Masaya Yamamoto | Neuroscience Discoveries | Research Excellence Award

Dr. Masaya Yamamoto | Neuroscience Discoveries | Research Excellence Award

Molecular Neuroscience Systems, Laboratory Medical Institute of Bioregulation, Kyushu University | Japan

Dr. Masaya Yamamoto is a Postdoctoral Researcher in the Molecular Neuroscience Systems Laboratory at the Medical Institute of Bioregulation, Kyushu University. Trained as a physician-scientist, he holds an M.D. and a Ph.D. in Medical Science, with advanced expertise in molecular neuroscience and neurodegenerative disorders. His academic background combines rigorous clinical insight with cutting-edge basic research, positioning him at the forefront of modern brain science. Dr. Yamamoto’s research centers on uncovering how astrocytes actively regulate learning, memory, and synaptic plasticity. Moving beyond the traditional view of astrocytes as passive support cells, his work highlights their dynamic roles in cognitive processing. By integrating molecular neuroscience, in vivo imaging, and spatiotemporal proteomics, he investigates neuron–glia interactions across multiple biological scales. His research portfolio includes several completed and ongoing projects that collectively aim to decode the cellular and molecular logic underlying cognitive function and neurodegeneration. He has published peer-reviewed research and review articles in internationally recognized journals, including Neurotherapeutics and Cells. Notably, his integrative review work has provided a unifying framework that connects nanoscale astrocytic calcium signaling, multisynaptic integration, and network-level astrocyte ensemble dynamics. This synthesis has contributed to a paradigm shift in understanding how astrocytes influence memory formation and information processing in the brain. Dr. Yamamoto is an active member of the Japanese Society for Neurochemistry and contributes to the scientific community through interdisciplinary research that bridges molecular, cellular, and systems neuroscience. Although he has not yet pursued patents, consultancy, or editorial roles, his work demonstrates strong translational potential, particularly in the context of neurodegenerative and cognitive disorders. Through his innovative research approach and conceptual contributions, Dr. Yamamoto has helped redefine the role of glial cells in cognition. His achievements reflect a strong commitment to research excellence, making him a highly suitable candidate for the Research Excellence Award.


View ORCID Profile

Featured Publications

Fatemeh Rezaei-Tazangi | Neuroscience Discoveries | Best Research Article Award

Dr. Fatemeh Rezaei-Tazangi | Neuroscience Discoveries | Best Research Article Award

Fasa University of Medical Sciences | Iran

Dr. Fatemeh Rezaei-Tazangi, affiliated with Fasa University of Medical Sciences, Iran, is a distinguished researcher in the fields of stem cells, reproductive medicine, cancer biology, and herbal therapeutics. She holds a Ph.D. in Anatomical Sciences from Ahvaz Jundishapur University of Medical Sciences, building on her earlier studies in midwifery and anatomical sciences at Shiraz University of Medical Sciences. Her scholarly contributions are widely recognized, with 59 published documents indexed in Scopus, cited by 568 publications, amounting to 630 citations and an h-index of 13, reflecting the strong impact of her research. Dr. Rezaei-Tazangi’s investigations bridge experimental and translational science, with a special focus on mesenchymal stem cells, oxidative stress, fertility preservation, and the therapeutic promise of natural compounds and nano-based drug formulations. She has provided valuable insights into mechanisms such as ferroptosis, autophagy, epithelial-mesenchymal transition, and stem cell-derived secretomes in relation to cancer and regenerative medicine. Her collaborative research record includes work with over 260 co-authors, highlighting her active engagement with the global scientific community. By combining advanced cellular biology with herbal and nanotechnology-based approaches, she contributes to the development of innovative strategies for reproductive health and oncology. With a growing research impact and a diverse body of work, Dr. Rezaei-Tazangi is an emerging leader in biomedical sciences, committed to advancing healthcare solutions through interdisciplinary and impactful research.

Profile: Scopus Google Scholar Orcid

Featured Publications

“Receptor tyrosine kinase inhibitors in cancer”

“Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy”

“Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance”

“The emerging role of regulatory cell-based therapy in autoimmune disease”

“Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology”

“Taurine effects on Bisphenol A-induced oxidative stress in the mouse testicular mitochondria and sperm motility”

“Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response”

“The therapeutic potential of common herbal and nano-based herbal formulations against ovarian cancer: New insight into the current evidence”

“Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer”

“Quercetin and Osteoarthritis: A Mechanistic Review on the Present Documents”

“The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma”

“A review of methods for preserving male fertility”

“Can mesenchymal stem cells derived from adipose tissue and their conditioned medium improve ovarian functions? A mini-review”

“Effects of Wharton’s jelly mesenchymal stem cells-derived secretome on colon carcinoma HT-29 cells”